Skip to Content

Investor Relations

BioScrip®, Inc. is the largest independent national provider of infusion and home care management solutions, with approximately 2,200 teammates and nearly 80 service locations across the U.S...
Read More

Corporate Profile

BioScrip®, Inc. is the largest independent national provider of infusion and home care management solutions, with approximately 2,200 teammates and nearly 80 service locations across the U.S. BioScrip partners with physicians, hospital systems, payors, pharmaceutical manufacturers and skilled nursing facilities to provide patients access to post-acute care services. BioScrip operates with a commitment to bring customer-focused pharmacy and related healthcare infusion therapy services into the home or alternate-site setting. By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by clinical excellence, customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves.

Investor Overview

News Releases

Date Title and Summary
Toggle Summary BioScrip Announces U.S. Congress Passage of Medicare Home Infusion Transition Benefit, Effective 2019
DENVER --(BUSINESS WIRE)--Feb. 9, 2018-- BioScrip, Inc. (NASDAQ:BIOS) (" BioScrip " or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the U.S. Congress today passed the Medicare Home Infusion Therapy Access Act of 2017
Toggle Summary BioScrip Announces Availability of HEMLIBRA® for Hemophilia Patients
DENVER , Jan. 08, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that it can now dispense and administer HEMLIBRA® (emicizumab-kxwh), a U.S.
Toggle Summary BioScrip to Host Meetings at the Mizuho Investor Conference
DENVER , Nov. 30, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf , President and Chief Executive Officer, and Stephen Deitsch ,